Mode
Text Size
Log in / Sign up
N/A Completed N=1,663

Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED)

Primary Hypercholesterolemia
Source: ClinicalTrials.gov NCT00724477 ↗
Enrolled (actual)
1,663
Serious AEs
0.1%
Results posted
Feb 2010
Primary outcomePrimary: Number of Participants Reaching the Targeted LDL-C Levels — 740 Participants

Summary

The main objective of this study is to determine the percentage of patients who met the low-density lipoprotein cholesterol (LDL-C) objective with INEGY, that were not under statin monotherapy treatment.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Reaching the Targeted LDL-C Levels
740 —

Eligibility Criteria

Inclusion Criteria

  • man or woman aged over 18;
  • patient suffering from primary hypercholesterolemia;
  • patient justifying treatment with INEGY® (2nd intention);
  • patient currently treated with INEGY® for at least 4 weeks;
  • patient with a lipid profile before treatment with INEGY®, documenting a level of LDL-C exceeding the therapeutic objective under treatment with a statin as monotherapy;
  • patient with an evaluation of lipid disorder (EAL) treated with INEGY®, performed within 1 to 3 months of starting treatment.

Exclusion Criteria

  • patient not previously treated with a statin;
  • patient previously treated with a combination of hypolipemics;
  • patient treated with INEGY® as first intention;
  • patient treated with INEGY® for less than 4 weeks;
  • patient already included in this study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00724477). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search